Ποια είναι η τιμή για PharmaSGP Holding SE (PSG)

Η τιμή για PharmaSGP Holding SE (PSG) είναι $34.40

Ποια είναι η κεφαλαιοποίηση αγοράς για PharmaSGP Holding SE (PSG)

Η κεφαλαιοποίηση αγοράς για PharmaSGP Holding SE (PSG) είναι $396.01M

PharmaSGP Holding SE (PSG) Τιμή και Κεφαλαιοποίηση Αγοράς

Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE specializes in the production of over-the-counter (OTC) pharmaceuticals and diverse healthcare goods. The company offers an extensive portfolio of products addressing various health concerns. This includes Baldriparan for sleep disturbances; pain relief solutions like Spalt, Formigran, and Kamol massage cream; RubaXX, specifically designed for rheumatic pain in bones, tendons, and muscles; and Restaxil, which targets nerve pain in the neck and back. Furthermore, their offerings encompass Fulminan, a beauty beverage for areas such as the eyes, buttocks, and thighs; DESEO drops for sexual weakness; Neradin, a medication for sexual dysfunction; and TAUMEA, aimed at managing vertigo. PharmaSGP also develops treatments for chronic conditions, including persistent pain and other age-associated ailments. Its products reach consumers via pharmacies and wholesalers, and are exported to several European nations, including Austria, Italy, Belgium, Spain, and France.

Η τιμή για PSG	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$462,697 $396.01M	NVDA	$5.327T	+1,345,009.15%
$403,464 $396.01M	AAPL	$4.645T	+1,172,810.86%
$353,551 $396.01M	GOOG	$4.070T	+1,027,710.47%
$328,737 $396.01M	MSFT	$3.785T	+955,571.34%
$242,356 $396.01M	AMZN	$2.790T	+704,453.82%

Η τιμή για PSG

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$462,697 $396.01M